US 11028120
CD73 inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 11028120 (CD73 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ORIC PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00